§ Procaine Periarticular Injections for Pain Reduction in Elderly With Osteoarthritis
Complementary Treatment With Procaine Periarticular Injections for Pain Reduction and Functional Improvement in Elderly Individuals With Osteoarthritis
1 other identifier
interventional
203
1 country
1
Brief Summary
§ The goal of this clinical trial is to assess the effect of periarticular procaine injections combined with physical therapy on joint pain in individuals 65 and older suffering from osteoarthritis of the hip or the knee. The main question it aims to answer is: Is procaine effective in decreasing joint pain? Researchers will compare procaine injections combined with physical therapy to physical therapy only to evaluate whether or not procaine helps decrease joint pain. Participants will: Undergo procaine periarticular injections and physical therapy Assess their symptoms and pain using scales and tests provided
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Feb 2024
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedFirst Submitted
Initial submission to the registry
November 30, 2024
CompletedFirst Posted
Study publicly available on registry
December 5, 2024
CompletedDecember 5, 2024
February 1, 2024
4 months
November 30, 2024
November 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Levels
Change in Pain Level on Visual Analogue Scale (VAS)
Baseline to Day 10
Secondary Outcomes (3)
Functional Improvement
Baseline to Day 10
ADL and IADL Scores
Baseline to Day 10
Geriatric Depression Scale
Baseline to Day 10
Study Arms (2)
Experimental
EXPERIMENTALParticipants in the experimental arm received daily periarticular injections of procaine complex solution (5 ml containing 100 mg procaine hydrochloride) over a 10-day period. All injections were administered using sterile technique. Prior to treatment, sensitivity to procaine hydrochloride was assessed with a subcutaneous test dose (0.5 ml)
Control
ACTIVE COMPARATORParticipants received only physical therapy without procaine injections.
Interventions
Participants will receive periarticular 5 ml procaine injections targeting painful joints for 10 consecutive days alternating between knee- and/or hip joints
Eligibility Criteria
You may qualify if:
- Adults aged 65 and older diagnosed with knee or hip osteoarthritis per the American College of Rheumatology criteria. Must exhibit radiographic evidence of OA and experience persistent joint pain
You may not qualify if:
- Individuals with Alzheimer's, severe depression, cancer, or other severe health conditions, and those with allergies to procaine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
"Sf. Luca" Chronic Disease Hospital
Bucharest, Romania
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sorina Maria Aurelian
"Carol Davila" University of Medicine and Pharmacy Geriatrics and Gerontology Clinic, "Sf. Luca" Chronic Disease Hospital Bucharest
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 30, 2024
First Posted
December 5, 2024
Study Start
February 8, 2024
Primary Completion
June 8, 2024
Study Completion
October 30, 2024
Last Updated
December 5, 2024
Record last verified: 2024-02